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In tro duc tion: Gil be rt’s syndro me is the mo st com mon he re di ta ry di sor der of bi li ru bin me ta bo li sm. The cau sa ti ve mu ta tion in Cau ca sia ns is al mo st 
exclu si ve ly a (TA) di nuc leo ti de in ser tion in the UG T1A1 pro mo ter. Aff ec ted in di vi dua ls are ho mo zygous for the va ria nt pro mo ter and ha ve 7 TA re pea-
ts in stead of 6. Pro mo te rs wi th 5 and 8 TA re pea ts al so exi st but are extre me ly ra re in Cau ca sia ns. The aim of our stu dy was to de ve lop de na tu ri ng 
hi gh-per for man ce liquid chro ma tog rap hy (DHPLC) as say for ge no typi ng UGT1A1(TA)n po lymor phi sm and to com pa re it wi th a pre vious ly des cri bed 
sin gle-stra nd con for ma tion po lymor phi sm (SSCP) as say.
Ma te ria ls and met ho ds: Fif ty DNA sam ples wi th com mon ge no types ((TA)6/6, (TA)6/7, (TA)7/7) as we ll as 7 sam ples wi th one of the fol lowi ng ra re 
ge no types - (TA)5/6, (TA)5/7, (TA)6/8 or (TA)7/8 we re am pli fi ed by po lyme ra se chain reac tion (PCR) and ge no typed by DHPLC usi ng si zi ng mo de. All sam-
ples we re pre vious ly ge no typed by SSCP as say whi ch was va li da ted by sequen ci ng ana lysis.
Re sul ts: All sam ples wi th eit her com mon or ra re ge no types showed com ple te ly con cor da nt re sul ts be tween DHPLC and SSCP as says. Our re sul ts 
show that si zi ng DHPLC as say is mo re effi   cie nt com pa red to clas si cal SSCP as say due to shor ter time of ge no typi ng ana lysis, abi li ty of ge no typi ng 
in crea sed num ber of sam ples per day, hig her ro bus tne ss, rep ro du ci bi li ty and co st-eff ec ti ve ne ss wi th no lo ss of ac cu ra cy in de tec tion of all UG T1A1(TA)n 
ge no types.
Con clu sio ns: We de ve lo ped a new DHPLC as say whi ch is sui tab le for ac cu ra te, au to ma ted, highthroug hput, ro bu st ge no typi ng of all UG T1A1(TA)n 
po lymor phi sm va rian ts, com pa red to a la bour in ten si ve and ti me-con su mi ng SSCP as say.
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Original article
In tro duc tion
U DP-glu cu ro no syltran sfe ra se 1A1 (UG T1A1) is the 
on ly physio lo gi cal ly re le va nt en zyme for bi li ru bin 
glu cu ro ni da tion in hu ma ns (1). Sequen ce va ria tio-
ns in the UG T1A1 en co di ng ge ne (UG T1A1) that 
dec rea se the en zyme ac ti vi ty are res pon sib le for 
in he ri ted un co nju ga ted hyper bi li ru bi ne mias ran-
gi ng from Gil ber t's syndro me (GS) (30% ac ti vi ty) to 
Crig le r-Naj jar syndro me type II (10% ac ti vi ty) and 
Crig le r-Naj jar syndro me type I (0% ac ti vi ty) (2,3). 
Whi le bo th Crig le r-Naj jar syndro mes are ve ry ra re, 
GS is qui te com mon (4). On the ba sis of se rum bi li-
ru bin con cen tra tion, 3-10% of the ge ne ral po pu la-
tion are es ti ma ted to ha ve GS. The con di tion is 
cha rac te ri sed by in ter mit te nt mi ld un co nju ga ted 
hyper bi li ru bi ne mia in the ab sen ce of he mo lysis or 
evi den ce of li ver di sea se (2,5). The cau sa ti ve 
sequen ce va ria tion in Cau ca sia ns is al mo st exclu si-
ve ly a (TA) di nuc leo ti de in ser tion in the TA TA-box 
of the UG T1A1 pro mo ter. Aff ec ted in di vi dua ls are 
ho mo zygous for the va ria nt pro mo ter and ha ve 7 
TA re pea ts in stead of 6 TA re pea ts (6). The frequen-
cy of (TA)7/7 ge no type in Cau ca sia ns is 11-16% (4). 
Pro mo te rs wi th 5 and 8 TA re pea ts ha ve al so been 
iden ti fi ed; fi r st in in di vi dua ls of Af ri can des ce nt 
and sub sequen tly in Cau ca sia ns, whe re they are 
extre me ly ra re (7-11). An in crea se in pro mo ter len-
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gth re sul ts in a dec rea se in en zyme tran scrip tion 
and the re fo re dec rea sed co nju ga tion of bi li ru bin 
(7,8,12). Al thou gh GS is qui te be ni gn from a he pa-
to lo gi cal poi nt of view, scree ni ng for this syndro-
me is im por ta nt cli ni cal ly in the diff e ren tial diag-
no sis of jaun di ce and be cau se the se sub jec ts may 
be mo re sus cep tib le to the ad ver se eff ec ts of seve-
ral dru gs that are me ta bo li sed by UG T1A1, su ch as 
iri no te can (9,31). In ad di tion, the UG T1A1(TA)n po-
lymor phi sm has been as so cia ted wi th neo na tal 
hyper bi li ru bi ne mia, hyper bi li ru bi ne mia and an in-
crea sed li ke li hood of gal lsto ne for ma tion in se ve-
ral in he ri ted hae ma to lo gi cal di sor de rs and in cyst-
ic fi b ro sis (4,10).
Se ve ral met ho ds for ge no typi ng the UG T1A1(TA)n 
po lymor phi sm ba sed on diff e ren tia tion ac cor di ng 
to the len gth, con for ma tion or mel ti ng be ha viour 
of the frag men ts ha ve been re por ted. They diff er 
wi th res pe ct to throug hput, co st, spe ci fi  ci ty and 
sen si ti vi ty, as we ll as the ma nual wo rk requi red, ti-
me, spe cial in stru men ts and ot her cha rac te ris ti cs. 
Be si des sequen ci ng wi th fl uo res cen ce-ba sed di-
deoxy chain ter mi na tor met hod, diff e re nt frag me-
nt ana lyses, the Invader® as say, rea l-ti me fl uo res ce-
nt PCR usi ng hydro lysis or hybri di za tion pro bes, 
pyro sequen ci ng, sin gle stra nd con for ma tion po-
lymor phi sm (SSCP), hi gh re so lu tion mel ti ng and 
de na tu ri ng hi gh per for man ce liquid cro ma tog rap-
hy (DHPLC) ana lyses ha ve been des cri bed (8-10,14-
19). DHPLC is com mon ly used to iden ti fy sin gle 
nuc leo ti de sub sti tu tio ns as we ll as sma ll in ser tio ns 
and de le tio ns for mu ta tion de tec tion and ge no-
typi ng un der par tial ly de na tu ri ng con di tio ns (20). 
To mu ch les ser exte nt, the DHPLC si zi ng met hod 
can al so be ap plied for ge no typi ng (21).
The two pub lis hed DHPLC as says enab le se pa ra-
tion of the three com mon ge no types (TA(6/6), TA(6/7) 
and TA(7/7)) usi ng eit her par tial ly de na tu ri ng or ful-
ly de na tu ri ng con di tio ns. Howe ver, no pro to co ls 
for si mul ta neous ge no typi ng of com mon and ra re 
ge no types of the UG T1A1(TA)n po lymor phi sm usi-
ng DHPLC met hod ha ve been des cri bed so far.
In this stu dy we pre se nt a new si zi ng DHPLC as say 
for si mul ta neous ge no typi ng of com mon and ra re 
UG T1A1(TA)n va rian ts and com pa re it wi th the pre-
vious ly des cri bed SSCP as say.
Ma te ria ls and met ho ds
Ma te ria ls
Fif ty-se ven DNA sam ples, whi ch ha ve been pre-
vious ly ge no typed by SSCP as say we re in clu ded in 
the stu dy. Ge no mic DNA was iso la ted from pe rip-
he ral blood leu ko cytes usi ng Flexi Ge ne DNA kit 
(Qia gen, Hil den, Ger ma ny). The stu dy was con duc-
ted ac cor di ng to the Dec la ra tion of Hel sin ki and 
ap pro ved by the Et hi cal Com mit tee of the Re pub-
lic of Slo ve nia, No. 33/05/04. Sub jec ts’ writ ten in-
for med con sen ts we re ob tai ned be fo re en te ri ng 
the stu dy.
Met ho ds
Ge no typi ng of UGT1A1(TA)n pro mo ter
po lymor phi sm by SSCP as say
The num ber of TA re pea ts was de ter mi ned by po-
lyme ra se chain reac tion (PCR) fol lowed by sin gle-
stra nd con for ma tion po lymor phi sm ana lysis (SSCP) 
as pre vious ly des cri bed (10) Briefl y, UG T1A1 pro mo-
ter frag men ts 199-205 bp in len gth, de pen di ng on 
the num ber of TA re pea ts, we re am pli fi ed by PCR 
wi th pri me rs F: 5'-TGAAATTCCAGCCAGTTCAA-3' 
and R: 5'-AGAGGTTCGCCCTCTCCTAC-3'. SSCP ana-
lysis was run on 8% (37:1) po lyac ryla mi de ge ls in a 
Pro tean II elec trop ho re sis unit (Bio-Rad La bo ra to-
ries Inc., Her cu les, CA) in 0.5X TBE buff er (50 mM 
Tri s-bo ra te, pH 8.3 and 0.5 mM EDTA) at a con sta nt 
power of 20 wat ts at 9 °C for 3.5 h. Af ter elec trop-
ho re sis SSCP pat ter ns we re vi sua li zed by sil ver stai-
ni ng. The geno type of PCR pro duc ts cor res pon di-
ng to ea ch SSCP pat te rn we re de ter mi ned by 
sequen ci ng, per for med by MWG Bio te ch AG (Eber-
sbe rg, Ger ma ny) wi th the Va lue Read Ser vi ce, ap-
plyi ng the fl uo res cen ce-ba sed di deoxy chain ter-
mi na tor met hod.
Ge no types we re as sig ned as fol lows:
(TA)• 5/6 (he te ro zygote wi th 5 TA and 6 TA re pea ts);
(TA)• 5/7 (he te ro zygo te wi th 5 TA and 7 TA re pea ts);
(TA)• 6/6 (ho mo zygo te wi th 6 TA re pea ts);
(TA)• 6/7 (he te ro zygo te wi th 6 TA and 7 TA re pea ts);
(TA)• 7/7 (ho mo zygo te wi th 7 TA re pea ts);
(TA)• 6/8 (he te ro zygo te wi th 6 TA and 8 TA re pea ts); 
and
(TA)• 7/8 he te ro zygo te wi th 7 TA and 8 TA re pea ts).
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Ge no typi ng of UGT1A1(TA)n pro mo ter
po lymor phi sm by DHPLC as say
For DHPLC ana lysis a new pair of pri me rs was de-
sig ned for am pli fi  ca tion of UG T1A1 pro mo ter frag-
men ts 71-77 bp in len gth, de pen di ng on the num-
ber of TA re pea ts. The sequen ces of pri me rs we re 
as F: 5‘-CA CAG TCAAA CAT TAACTTGGTG-3‘, R:
5‘-GTTCGCCCTCTCCTAC TT-3‘. Oli go nuc leo ti de pri-
me rs we re de sig ned ba sed on the sequen ce of the 
UG T1A1 ge ne avai lab le in Ge ne ba nk (ac ces sion no. 
AF352795.1) usi ng mu ta tion dis co ve ry.com. The 
PCR reac tion mixtu re (25 μL) con tai ned ge no mic 
DNA (100 ng), 1X PCR buff er, 0.2 mM ea ch of the 
four deoxyri bo nuc leo ti des, 2.0 mM MgCl2, 0.25 
mM ea ch of the two oli go nuc leo ti de pri me rs and 
0.5 uni ts of Am pli Taq GoldTM po lyme ra se (Ap-
plied Bio syste ms, Fos ter Ci ty, CA). Cycli ng con ditio-
ns con sis ted of an ini tial 10 min at 95 °C, fol lowed 
by 38 cycles of 30 s at 95 °C, 30 s at 57 °C and 20 s at 
72 °C, and a fi  nal 7 min at 72 °C. Aliquo ts of PCR pro-
duc ts we re elec trop ho re sed on 2% aga ro se gel to 
che ck their qua li ty and quan ti ty.
8 μl of the PCR pro duc ts we re fur ther injec ted on-
to a pre hea ted re ver se-pha se co lu mn (DNA Sep 
Co lu mn, Tran sge no mic Ltd, Oma ha, USA) of a 
WAVE MD DHPLC system (Tran sge no mic Ltd, Oma-
ha, USA) equi lib ra ted by an ion pai ri ng age nt TEAA 
0.1 M (Triet hylam mo nium ace ta te). UG T1A1 pro mo-
ter (TA)n re peat po lymor phi sm was de ter mi ned 
usi ng a si zi ng mo de by a li near ace to nit ri le gra die-
nt, ac hie ved by mixi ng a buff er A (TEAA 0.1 M) wi-
th a buff er B (TEAA 0.1 M and ace to nit ri le 25%) wi-
th 1.8% per mi nu te gra die nt in crea se from the sta-
rt gra die nt of 40% up to stop gra die nt of 48.1% of 
the buff er B at con sta nt tem pe ra tu re 50 °C and 
con sta nt fl ow ra te of 0.9 mL/min. The elu ted DNA 
was de tec ted at 260 nm. Ge no types of 57 in di vi-
dual PCRs we re de ter mi ned usi ng the si zi ng cal li-
ng rou ti ne (Tran sge no mic Na vi ga tor Sof twa re 
1.6.2.). De tai ls of the DHPLC pro to col are lis ted in 
Tab le 1.
Re sul ts
Ge no type dis tri bu tion, sam ple er ro rs and ti me of 
ana lysis usi ng DHPLC and SSCP as says
Fif ty-se ven sam ples we re ge no typed for the UG-
T1A1(TA)n po lymor phi sm twi ce, usi ng DHPLC and 
SSCP as says. The ge no type dis tri bu tion in our se-
lec ted stu dy group is pre sen ted in Tab le 2.
Our stu dy group was ab se nt of (TA)8/8 and (TA)5/5 
ho mo zygo tes and (TA)5/8 he te ro zygo tes. Mo st 
com mon ge no types we re (TA)6/7 and (TA)6/6. When 
com pa ri ng the ge no type re sul ts for ea ch sam ple 
ob tai ned by SSCP and DHPLC, no sam ple ge no-
type er ror was de tec ted (0%).
To ac hie ve effi   cie nt dis cri mi na tion be tween pea ks 
of ea ch UG T1A1(TA)n ge no type we dec rea sed the 
len gth of PCR am pli con (from 199-205 bp for SSCP 
to 71-77 bp for DHPLC ana lysis) and gra die nt incre-
ase of buff er B in DHPLC co lu mn was set up to on ly 
TAB LE 1. DHPLC pro to col usi ng si zi ng mo de
Step Ti me
(min)




Loa di ng 0 65 35
Sta rt Gra die nt 1 60 40
Stop Gra die nt 5.5 51.9 48.1
Sta rt Clean 5.6 65 35
Stop Clean 6.1 65 35
Sta rt Equi lib ra te 6.2 65 35
Stop Equi lib ra te 6.6 65 35
TAB LE 2. Dis tri bu tion of UG T1A1(TA)n ge no types de ter mi ned by 







TA(5/6) 2 (3.5) 2 (3.5)
TA(5/7) 1 (1.8) 1 (1.8)
TA(6/6) 18 (31.6) 18 (31.6)
TA(6/7) 24 (42.1) 24 (42.1)
TA(6/8) 2 (3.5) 2 (3.5)
TA(7/7) 8 (14.0) 8 (14.0)
TA(7/8) 2 (3.5) 2 (3.5)
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1.8% per mi nu te. The gra die nt in crea se fi  nis hed in 
48.1% of buff er B wi th the aim to shor ten the re-
ten tion ti me to on ly 6.6 mi nu tes. The 96-well pla te 
with 57 sam ples was ana lyzed wit hin cca 6 h and 
30 min usi ng DHPLC, whe reas the du ra tion of ana-
lysis of the sa me num ber of sam ples was cca 2 
wor ki ng-days usi ng SSCP as say.
Al le lic dis cri mi na tion of the com mon UGT1A1(TA)n 
po lymor phi sm ge no types
The sam ple wi th (TA)6/7 ge no type was used as a 
qua li ty con trol for de ter mi ni ng the com mon ge-
no types of UG T1A1 pro mo ter po lymor phi sm su ch 
as (TA)7/7, (TA)6/6 and (TA)6/7. We ll-re sol ved se pa ra-
tion of the chro ma tog ram pea ks be tween all three 
ge no types was ob ser ved. Al le lic si ze dis cri mi na-
tion of UG T1A1 pro mo ter (TA)6/6, (TA)6/7 and (TA)7/7 
repeat ge no types usi ng DHPLC as say is pre sen ted 
in Fi gu re 1. Sam ples wi th 6 TA and 7 TA re peat al le-
les elu ted from the co lu mn by showi ng the pea ks 
at a re ten tion ti me ran ges of 4.244-4.267 min and 
4.408-4.428 min, res pec ti ve ly. The ear ly elu ti ng 
(TA)6/6 and la ter elu ti ng (TA)7/7 ge no type pea ks 
showed 2-times hig her pea ks com pa red to pea ks 
of he te ro zygo tes ((TA)6/7) wi th ad di tio nal sma ll 
peak elu ted ear lier. The pea ks of (TA)6/7 he te ro-
zygo tes we re doub le ha vi ng the sa me re ten tion ti-
mes for 6 and 7 TA re peat al le les as of the ho mo-
zygo tes (TA)6/6 and (TA)7/7. The ti me shif ti ng was 
ve ry slig ht or ab se nt at the sa me co lu mn pres su re 
and buff er con di tio ns.
Al le lic dis cri mi na tion of the ra re UGT1A1(TA)n
po lymor phi sm ge no types
For de ter mi na tion of the (TA)5/6 and (TA)77 or (TA)7/8 
and (TA)7/7 ge no types of UGT1A1 pro mo ter po-
lymor phi sm the be st qua li ty con tro ls for ac cu ra te 
ge no typi ng we re tho se wi th (TA)5/7 or (TA)6/8 ge-
no types, res pec ti ve ly. Al le lic si ze dis cri mi na tion of 
UG T1A1 pro mo ter (TA)5/6, (TA)7/7 and (TA)5/7 (a) and 
(TA)6/8, (TA)7/8 and (TA)7/7 (b) re peat ge no types usi-










FI GU RE 1. Exam ple chro ma tog ra ms from DHPLC si zi ng as say.
FI GU RE 2. Al le lic dis cri mi na tion of UG T1A1-pro mo ter (TA)5-7 (a) 



















Sam ples wi th 5 TA and 8 TA re peat al le les elu ted 
from the co lu mn showi ng the pea ks at a re ten tion 
ti me ran ge of 4.076-4.104 min and 4.610 min, res-
pec ti ve ly.
The chro ma tog ra ms showed doub le pea ks in he-
te ro zygo te sam ples wi th ad di tio nal sma ll peak elu-
ted ear lier, whe reas the chro ma tog ra ms of ho mo-
zygous sam ples showed on ly one elu tion peak 
whi ch was 2-times hig her than in he te ro zygo tes.
Dis cus sion
The pre se nt stu dy is the fi r st to show the co st-ef-
fec ti ve, ti me-sa vi ng, ac cu ra te and ra pid met hod 
for si mul ta neous ge no typi ng of ra re and com mon 
UG T1A1(TA)n pro mo ter re peat ge no types in newly 
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op ti mi sed con di tio ns usi ng si zi ng DHPLC met hod 
wi th the 100% ge no type con cor dan ce ra te wi th 
SSCP.
UG T1A1(TA)n ge no typi ng of pa tien ts cli ni cal ly sus-
pec ted of ha vi ng Gil be rt syndro me can con tri bu te 
to the con fi r ma tion of diag no sis, and may be im-
por ta nt in in di vi dua li sa tion of the ra py for dru gs 
that are me ta bo li sed by UG T1A1.
Rou ti ne met ho ds, su ch as SSCP, hi gh re so lu tion 
po lyac ryla mi de gel elec trop ho re sis (PAGE), real ti-
me fl uo res ce nt PCR, pyro sequen ci ng, and di re ct 
sequen ci ng ha ve been used for ge no typi ng of UG-
T1A1(TA)n pro mo ter re peat po lymor phi sm (15) and 
al so a DHPLC met hod has been re cen tly in tro du-
ced to ma ny la bo ra to ries (17,19). Our expe rien ce is 
that the DHPLC tec hnique is use ful in po lymor phi-
sm de tec tion in he te ro ge nous et hnic po pu la tio ns. 
Mo reo ver, to da te no stu dies ha ve shown the as-
ses sme nt of bo th ra re and com mon ge no types of 
the UG T1A1(TA)n po lymor phi sm si mul ta neous ly 
usi ng DHPLC met hod.
In this stu dy, we com pa red the UG T1A1(TA)n re peat 
po lymor phi sm ge no typi ng in se lec ted Slo ve nian 
pa tien ts usi ng DHPLC and SSCP met ho ds. Shor ter 
PCR am pli co ns we re pre pa red usi ng pri me rs spe-
ci fi c for DHPLC clo se ly fl an ki ng the UG T1A1 re gion 
wi th po lymor phic (TA)5-8 re pea ts to ac hie ve bet ter 
se pa ra tion of chro ma tog ram pea ks com pa red to 
lon ger PCR am pli co ns used for SSCP.
The exa ct lengths of UG T1A1(TA)n al le les we re de-
ter mi ned by run ni ng of UG T1A1(TA)n al le lic si zi ng 
con tro ls ge ne ra ted from he te ro zygous in di vi dua ls. 
The lengths of UG T1A1(TA)n al le lic si zi ng con tro ls 
we re cha rac te ri zed al so by SSCP met hod. Usi ng 
our DHPLC pro to col, we we re ab le to eff ec ti ve ly 
ge no type 57 se lec ted sam ples. Al so ra re 7/8, 5/7, 
5/6 and 6/8 TA re pea ts ge no types in 2, 1, 2 and 2 
sub jec ts we re clear ly ge no typed, res pec ti ve ly, usi-
ng the si zi ng met hod on DHPLC as we ll as SSCP.
The pat te rn of the elu tion pro fi  le for he te ro zygo-
tes and ho mo zygo tes sam ples has shown that no-
n-de na tu ri ng or si zi ng tec hnique enab les to dis tin-
gui sh be tween all ge no types of UG T1A1(TA)n po-
lymor phi sm wi th no pre vious need for mixi ng of 
un known ho mo zygous PCR pro duc ts wi th the 
known con trol ho mo zygo tes and de na tu ri ng/rea-
nnealing step be fo re DHPLC run com pa red to de-
na tu ri ng tec hnique (19). Due to avoi dan ce of re-
peat ana lyses, the si zi ng met hod is mo re ra pid and 
co st-eff ec ti ve and the la bor requi re men ts are thus 
re du ced. Mo reo ver, the stu dy by Pi rul li et al. (19) 
pre sen ted on ly the chro ma tog ram pea ks se pa ra-
tion be tween 7/7, 6/6 and 6/7 TA re pea ts ge no-
types, whe reas our stu dy showed al so the se pa ra-
tion of ot her UG T1A1(TA)n ge no types oc cur ri ng in 
our po pu la tion. Mo reo ver, Har raway et al. (17) 
sepa ra ted PCR pro duc ts ba sed on mo le cu lar weig-
ht on ly. Howe ver, they showed peak se pa ra tion 
be tween on ly 6-TA and 7-TA re pea ts usi ng ful ly de-
na tu ri ng con di tio ns on DHPLC. To da te no stu dy 
has shown the si zi ng se pa ra tion of all re pea ts si-
mul ta neous ly ((TA)5/7, (TA)6/7, (TA)7/8) usi ng on ly 50 
°C on DHPLC. Due to usi ng lower ana lysis tem pe-
ra tu re in our con di tio ns rat her than ful ly de na tu ri-
ng con di tio ns (80%) (17) the run ti me of our sam-
ple ana lysis was then ad di tio nal ly shor ter.
Our ap proa ch is sim ple, requi ri ng on ly one PCR 
reac tion wi th un la be led pri me rs and usi ng lowe r-
co st rea gen ts than di re ct sequen ci ng and real ti-
me fl uo res cen ce PCR.
All DHPLC-a na lyzed PCR sam ples we re al so run on 
the SSCP ge ls. Usi ng DHPLC ana lysis, no sam ple 
was de ter mi ned in cor rec tly (0%). Fur ther mo re, the 
sam ples ana lysis DHPLC run ta kes on ly 6.6 min, 
the re fo re, ope ra ti ng ti mes are shor ter and la bor 
co st lower than wi th SSCP met hod. Mo reo ver, the 
SSCP as say for ge no typi ng of eit her one or ten 
sam ples nee ds the sa me ti me-con su mi ng pre-a-
na lysis pre pa ra tion of ge ls and buff e rs, and de tec-
tion oc cu rs un der the toxic con di tio ns usi ng sil ver 
stai ni ng of ge ls what is not nee ded for au to ma ted 
DHPLC ana lysis.
Du ri ng our ru ns on DHPLC, the slig ht ti me shif ti ng 
of in di vi dual chro ma tog ra ms we re seen, howe ver 
the de ter mi na tion of true si ze of PCR frag me nt and 
then UG T1A1(TA)n ge no type was sti ll clear wi th no 
de tec tion er ror. To over co me inap prop ria te si zi ng 
of in di vi dual al le les cau sed by slig ht ti me shif ti ng 
of in di vi dual chro ma tog ra ms du ri ng ru ns, the im-
ple men ta tion of the qua li ty con tro ls wi th the 
known lengths of PCR am pli co ns we re used in in-
di vi dual we ll of ea ch run ni ng pla te.
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The cri ti cal poin ts du ri ng si zi ng DHPLC ana lysis 
we re the pres su re in the co lu mn, tem pe ra tu re, 
fl ow ra te, buff e r purity, DNA qua li ty as we ll as pri-
mer de si gn sin ce frag me nt lengths can al so aff e ct 
the DHPLC ana lysis ac cu ra cy.
The PCR am pli fi  ca tion of the sho rt po lymor phic 
re pea ts ge ne ra tes PCR ar ti fac ts cal led sha dow 
ban ds. Al thou gh their for ma tion is not we ll un der-
stood, it has been pro po sed that the sha dow ban-
ds are co mi ng from stut ter pro du ct as a re su lt of 
Am pli Taq Go ld po lyme ra se slip pa ge du ri ng DNA 
synthe sis (22). In our expe ri me nt, the amou nt of 
sha dow ban ds we re hig her in he te ro zygous sam-
ples, we as su me then that they cou ld rep re se nt 
the he te ro dup lexes for med by com ple men ta ry 
DNA stran ds of two al le les hybri di zi ng du ri ng the 
la st PCR cycles. Des pi te pre se nt sha dow ban ds the 
ge no type de tec tion was sti ll clear.
In con clu sion, we ha ve de ve lo ped a si zi ng DHPLC 
as say for si mul ta neous ge no typi ng of ra re and 
com mon UG T1A1(TA)n pro mo ter po lymor phi sm 
ge no types. We sug ge st this as say to be used as a 
ra pid, au to ma ted, ac cu ra te, and co st-eff ec ti ve al ter-
na ti ve met hod in rou ti ne cli ni cal la bo ra to ries whe-
re the DHPLC mac hi ne is avai lab le as we ll as in lar-
ge co ho rt ge ne ti cs stu dies ana lyzi ng UG T1A1(TA)n 
pro mo ter po lymor phic re pea ts.
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Raz voj no ve me to de DHPLC za ge no ti pi za ci ju po li mor fi z ma UG T1A1(TA)n 
po ve za nog s Gil ber to vim sin dro mom
Sažetak
Uvod: Gil ber tov sin drom je naj češ ći nas ljed ni po re me ćaj me ta bo liz ma bi li ru bi na. Kod bije la ca uz rok je is klju či vo in ser ci ja (TA) di nuk leo ti da u 
pro mo tor UG T1A1 ge na. Obo lje li po jed ni ci su ho mo zi go ti za va ri jan tni pro mo tor i ima ju 7 TA po nav lja nja um jes to 6. Pos to je i pro mo to ri s 5 i 8 TA 
po nav lja nja, no to su vr lo su ri jet ki slu ča je vi u po pu la ci ji bije la ca. Cilj na šeg is tra ži va nja bio je raz vi ti me to du te ku ćin ske de na tu ra cij ske kro ma-
tog ra fi  je vi so ke dje lot vor nos ti (en gl. de na tu ri ng hi gh-per for man ce liquid chro ma tog rap hy, DHPLC) za ge no ti pi za ci ju polimor fi z ma UG T1A1(TA)n te 
je us po re di ti s već opi sa nom me to dom ana li ze po li mor fi z ma kon for ma ci je jed no lan ča ne DNA (en gl. sin gle-stra nd con for ma tion po lymor phi sm, 
SSCP).
Ma te ri ja li i me to de: Pe de set uzo ra ka DNA uo bi ča je nih ge no ti po va ((TA)6/6, (TA)6/7, (TA)7/7) kao i se dam uzo ra ka s jed nim od slje de ćih, ri jet kih 
ge no ti po va – (TA)5/6, (TA)5/7, (TA)6/8 ili (TA)7/8 je na kon um na ža nja lan ča nom reak ci jom po li me ra ze ge no ti pi zi rano me to dom DHPLC uz prim je nu 
mo du la za us po red bu ve li či ne. Na svim je uzor ci ma pret hod no bi la nap rav lje na ge no ti pi za ci ja me to dom SSCP ko ja je va li di ra na sek ven ci ra njem.
Re zul ta ti: Svi uzor ci, i uo bi ča je nih i ri jet kih ge no ti po va, po ka za li su suk lad ne re zul ta te iz me đu me to da DHPLC i SSCP. Na ši re zul ta ti po ka zu ju da 
je mo dul us po red be ve li či ne kod DHPLC me to de učin ko vi ti ji u us po red bi s kla sič nom me to dom SSCP, zbog kra ćeg vre me na ana li ze ge no ti pi za ci je, 
mo guć nos ti ge no ti pi za ci je po ve ća nog bro ja uzo ra ka po da nu, po ve ća ne ro bus nos ti, po nov lji vos ti i troš kov ne učin ko vi tos ti bez gu bi ta ka na toč-
nos ti kod od re đi va nja svih ge no ti po va po li mor fi z ma UG T1A1(TA)n.
Zak lju čak: Raz vi li smo no vu me to du DHPLC ko ja je po god na za toč nu, au to ma ti zi ra nu, vi so ko učin ko vi tu, ro bus nu ge no ti pi za ci ju svih va ri jan ti 
po li mor fi z ma UG T1A1(TA)n u us po red bi s me to dom SSCP ko ja zah tje va dos ta ra da i vre me na.
Ključ ne ri je či: hi per bi li ru bi ne mi ja; mik ro sa te lit; far ma ko ge ne ti ka; SSCP; UG T1A1
